Top Story

GTX effective neoadjuvant treatment in locally advanced pancreatic cancer

January 29, 2015

Read the Perspective from Andrew H. Ko

Patients with locally advanced, unresectable pancreatic adenocarcinoma experienced favorable survival when they received neoadjuvant gemcitabine, docetaxel and capecitabine, according to study results.

Researchers observed the benefit among patients who subsequently underwent treatment with gemcitabine and capecitabine plus radiotherapy, as well as patients who did not undergo that subsequent treatment.

FDA News

Tarextumab granted orphan drug designation for pancreatic, small cell lung cancers

January 29, 2015
The FDA granted orphan drug designation to tarextumab for the treatment of pancreatic cancer and small cell lung cancer, the drug’s manufacturer announced…
In the Journals

Teledermoscopy accepted by patients, effective in monitoring atypical nevi

January 29, 2015
Patients were receptive to the use of teledermoscopy, which was effective for short-term monitoring of clinically atypical nevi, according to recently published study…
FDA News

FDA designates Neutrolin as QIDP

January 29, 2015
The FDA has designated a novel formulation as a qualified infectious disease product, for the prevention of catheter-related bloodstream infections for oncology…
In the Journals

Artificial hybrid likely required for treating giant cell tumor of bone with zoledronic acid

January 29, 2015
In a recently published study, researchers determined that to effectively treat giant cell tumors of bone with zoledronic acid, a hybrid including artificial bone would…
More News Headlines »
CME
Hot melanoma

Targeted Therapy and Immunotherapy in the Management of Metastatic Melanoma: 2014 Updates - Monograph

Melanoma remains a challenging condition for clinicians. An array of targeted therapies and immunotherapy are in…
More »
Meeting News Coverage Video
Genome editing demonstrated wide application for blood disorders

Genome editing demonstrated wide application for blood disorders

January 4, 2015
SAN FRANCISCO — Ralph Green, MD, PhD, FRCPath, medical director of the UC Davis Health System Medical…
More »
CME CNE
Low Risk AAMDS

Treatment Decision-Making through the Spectrum of MDS:
Case 1 Low Risk MDS

An educational presentation from Aplastic Anemia & MDS International Foundation.

MDS is a difficult disease to diagnose and treat. Frequently it is challenging for healthcare providers to explain MDS…
More »
morganatic-roan
morganatic-roan